With a mission to facilitate repetitive therapies for chronic disease patients, Access for Life’s medical technology helps reduce the rate of clinical complications due to vessel wall damage.

Given the challenges of taking a medical device company to market, MassChallenge provided industry mentors, lecturers on a wide range of topics, introductions to potential investors, and networking opportunities after the program ended to support Access for Life’s goals. During the past year, the team has received funding from local angel, won an EU Horizion 2010 grant, and was accepted into the prestigious Merage Institute in Irvine, CA.